Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways

UM > Institute of Chinese Medical Sciences

Residential College	false
Status	已發表Published
	Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways
	Xu, Cong 1; Zhang, Chen 2; Ganesan, Kumar 1; Chen, Qiu 3; Tang, Hailin 4; Gao, Fei 2; Liu, Qingqing 1; Wu, Jianming 4; Sui, Yue 1; Li, Peng5 ; Zhang, Jinming 2; Chen, Jianping 1,3
	2023-11
Source Publication	Current Medicinal Chemistry
Document Type	Journal article
Collection	Institute of Chinese Medical Sciences
Corresponding Author	Li, Peng; Zhang, Jinming; Chen, Jianping
Affiliation	1.The University of Hong Kong 2.Chengdu University of Traditional Chinese Medicine 3.Hospital of Chengdu University of Traditional Chinese Medicine 4.Sun Yat-Sen University Cancer Center 5.University of Macau
Corresponding Author Affilication	University of Macau
Recommended Citation GB/T 7714	Xu, Cong,Zhang, Chen,Ganesan, Kumar,et al. Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways[J]. Current Medicinal Chemistry, 2023.
APA	Xu, Cong., Zhang, Chen., Ganesan, Kumar., Chen, Qiu., Tang, Hailin., Gao, Fei., Liu, Qingqing., Wu, Jianming., Sui, Yue., Li, Peng., Zhang, Jinming., & Chen, Jianping (2023). Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways. Current Medicinal Chemistry.
MLA	Xu, Cong,et al."Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways".Current Medicinal Chemistry (2023).

Files in This Item:
There are no files associated with this item.

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Affiliation No.
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh